Tevogen Bio CEO reinforces commitment to retention of equity capitalon February 17, 2025 at 8:28 am MAK Gojar 1 year ago Post Content Post Content Share this: Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conferenceon February 5, 2025 at 12:16 pmDateFebruary 5, 2025In relation toMarkets NewsCan-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025on February 5, 2025 at 12:16 pmDateFebruary 5, 2025In relation toMarkets NewsAlkemy Capital secures £1.035 million in oversubscribed placingon February 17, 2025 at 7:08 amDateFebruary 17, 2025In relation toMarkets News
